EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Targeted delivery of BMPR2 mRNA attenuates pulmonary arterial hypertension by reversing pulmonary vascular remodeling

Yan Cao, Runyuan Wang, Xiaoyan He, Yan Ding, Yan Chang, Runyue Yang, Guisheng Zhong, Huiying Yang, Jianfeng Li

Acta Pharmaceutica Sinica B · 2025-10 · 15 (10) · 5416-5430

DOI: 10.1016/j.apsb.2025.07.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2025-10. Verfasst von Yan Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science and Technology & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, Chi…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Shanghai Municipality, ShanghaiTech University, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BMPR2 restorationDesign of ExperimentsHelper lipid-free LNPsLipid nanoparticlesProtein replacement therapyPulmonary arterial hypertensionPulmonary endothelial targetingmRNA delivery

Autor:innen und Institutionen

  • School of Life Science and Technology & State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai 201210, China.
  • Department of Pharmacy, School of Health and Nursing, Wuxi Taihu University, Wuxi 214063, China.
  • Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai 200030, China.
  • iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
  • Department of Pharmacy, Huashan Hospital, Fudan University, Shanghai 200040, China.
  • Shanghai Clinical Research and Trial Center, Shanghai 201210, China.

Förderung

  • Natural Science Foundation of Shanghai Municipality
  • ShanghaiTech University
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Cao, Y., Wang, R., He, X., Ding, Y., Chang, Y., Yang, R., Zhong, G., Yang, H., & Li, J. (2025). Targeted delivery of BMPR2 mRNA attenuates pulmonary arterial hypertension by reversing pulmonary vascular remodeling. Acta Pharmaceutica Sinica B, 15(10), 5416-5430. https://doi.org/10.1016/j.apsb.2025.07.004

Vancouver

Cao Y, Wang R, He X, Ding Y, Chang Y, Yang R, et al. Targeted delivery of BMPR2 mRNA attenuates pulmonary arterial hypertension by reversing pulmonary vascular remodeling. Acta Pharmaceutica Sinica B. 2025;15(10):5416-5430. doi:10.1016/j.apsb.2025.07.004

BibTeX
@article{Cao2025,
  author = {Cao, Yan and Wang, Runyuan and He, Xiaoyan and Ding, Yan and Chang, Yan and Yang, Runyue and Zhong, Guisheng and Yang, Huiying and Li, Jianfeng},
  title = {Targeted delivery of BMPR2 mRNA attenuates pulmonary arterial hypertension by reversing pulmonary vascular remodeling},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2025},
  volume = {15},
  number = {10},
  pages = {5416--5430},
  doi = {10.1016/j.apsb.2025.07.004}
}
Kostenlos starten →